Loading insider details...
Beta
Latest Form 4 (Jun 11, 2026): Grant/Award of 34,843 JBIO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | Jade Biosciences, Inc. (JBIO) | Grant/Award | 34,843 | n/a |
| May 1, 2026 | Avalyn Pharma Inc. (AVLN) | Grant/Award | 26,978 | n/a |
| May 1, 2025 | Jade Biosciences, Inc. (JBIO) | Grant/Award | 23,017 | n/a |
| Jun 9, 2023 | Neoleukin Therapeutics, Inc. (NLTX) | Grant/Award | 25,000 | n/a |
| Nov 2, 2022 | Eliem Therapeutics, Inc. (ELYM) | Grant/Award | 170,000 | n/a |
| May 16, 2022 | Neoleukin Therapeutics, Inc. (NLTX) | Grant/Award | 25,000 | n/a |
| Jan 31, 2022 | Eliem Therapeutics, Inc. (ELYM) | Grant/Award | 170,000 | n/a |